Clinical Trial Update: Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

View source ↗

Summary

A completed clinical trial assessed interferon-gamma and other inflammatory mediators in patients with malignancy-associated hemophagocytic lymphohistiocytosis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophagocytic Lymphohistiocytosis | Status: COMPLETED | Results posted: 2024-09-19